Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients Freedman O et al. - Factors predictive of being chemotherapy free at 3 months included older age, no prior adjuvant hormonal therapy, and the absence of lung or brain metastases at the start of therapy. A receiver operating characteristic (ROC) curve analysis had an area under the curve of 0.7 [more...]
